What are the drug interactions between azithromycin and levocetirizine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Drug Interactions Between Azithromycin and Levocetirizine

The combination of azithromycin and levocetirizine can be used together, but requires caution due to the potential for additive QT interval prolongation, particularly in patients with baseline QTc >377.5 ms or other cardiac risk factors.

Key Interaction: QT Prolongation Risk

The primary concern with this combination is additive cardiac effects on the QT interval. Azithromycin is recognized as a definite cause of QT prolongation and torsade de pointes 1, while cetirizine (the racemic mixture of levocetirizine) also has QT-prolonging potential.

Evidence from Direct Study

A prospective study specifically examining azithromycin and cetirizine combination demonstrated 2:

  • 95.6% of patients showed significant QTc increase by day 4 of treatment
  • 17.8% of patients exceeded the upper limit of normal QTc (>430 ms)
  • Critical threshold identified: baseline QTc >377.5 ms predicts risk of QTc prolongation above 430 ms with 87.5% sensitivity

The FDA label confirms azithromycin has only a modest effect on cetirizine pharmacokinetics with no dosage adjustment required 3, indicating no significant pharmacokinetic interaction—the concern is purely pharmacodynamic (additive cardiac effects).

Clinical Decision Algorithm

Before Prescribing This Combination:

1. Obtain baseline ECG if:

  • Patient has any cardiovascular disease
  • Baseline QTc suspected >377.5 ms
  • Patient is elderly or female (higher risk groups) 1
  • Patient takes other QT-prolonging medications
  • Electrolyte abnormalities present (hypokalemia, hypomagnesemia)

2. Avoid this combination entirely if:

  • Baseline QTc ≥500 ms 1
  • Known congenital long-QT syndrome 1
  • Recent cardiac arrhythmias

3. If prescribing in low-risk patients:

  • Young, healthy individuals
  • No cardiac history
  • No other QT-prolonging drugs
  • Normal electrolytes
  • Baseline QTc <377.5 ms
  • Can proceed without routine ECG monitoring 4

During Treatment:

Monitor for:

  • Palpitations, syncope, or dizziness
  • Consider repeat ECG on day 4 if baseline QTc was 377.5-430 ms
  • Discontinue both drugs if QTc exceeds 500 ms 1
  • Maintain normal potassium and magnesium levels

Important Caveats

Risk factors that amplify concern:

  • Advanced age (particularly >65 years)
  • Female sex 1
  • Fever or inflammatory states 1
  • Concurrent diuretic use
  • Renal impairment (increases azithromycin levels by 61% in severe cases) 3

Alternative considerations: When treating upper respiratory infections, consider whether both drugs are truly necessary. If cardiac risk exists, substitute with antibiotics that don't prolong QT (penicillins, cephalosporins) 4 or use non-sedating antihistamines with lower cardiac risk (loratadine, fexofenadine).

Practical Bottom Line

For otherwise healthy outpatients with upper respiratory infections and no cardiac risk factors, this combination is reasonable without extensive monitoring. However, any patient with baseline QTc >377.5 ms or cardiac risk factors requires ECG monitoring and consideration of alternative medications 2. The interaction is real and clinically significant, but manageable with appropriate risk stratification 1, 4.

References

1
Guideline

considerations for drug interactions on qtc interval in exploratory covid-19 treatment.

Journal of the American College of Cardiology, 2020

Related Questions

What is the recommended prophylactic (single‑dose) regimen of azithromycin (Zithromax) for adults and for children, including weight‑based dosing?
Can azithromycin (AZM) be given with antihistamines?
A patient allergic to Rocephin (ceftriaxone) and cephalosporins with a dental abscess and acute sinusitis—what azithromycin regimen is recommended?
What are examples of antibiotics, their coverage, side effects, and dosages in both oral and intravenous (IV) forms?
What oral antibiotic regimen is recommended as an alternative to levofloxacin for an immunocompromised patient with recurrent bronchitis?
How should a patient who is one month post carotid endarterectomy presenting with dizzy spells be evaluated and managed?
How long does it take for Intuniv ER (extended‑release guanfacine) to work?
Can fexofenadine and azithromycin be co‑administered safely in an adult patient, and are dose adjustments required in cases of hepatic disease or reduced renal function?
What does asymmetric enlargement of the left temporal horn on CT head indicate and what further evaluation is recommended?
What are the drug interactions between fexofenadine and levocetirizine?
Can major surgery in a 70‑ to 80‑year‑old patient precipitate Parkinson disease or a parkinsonian syndrome?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.